Skip to content
StockMarketAgent
Sector pending / Home Health Care ServicesUpdated 2026-05-10 22:07 UTC

FRA/X34 stock hub

FRA/X34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/X34is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
594.3M
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/X34FRA/X34
Loading chart…
In the news

Latest news · FRA/X34

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.3
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-0.2
P25 n/aP50 n/aP75 n/a
ROIC-11.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/X34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
175
Groups with data
11
Currency
USD
Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
10,800
Employees Change
-100%
Employees Change Percent
-0.93
Enterprise value
EUR 985.5M
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Home Health Care Services
Last refreshed
2026-05-10
Market cap
EUR 594.3M
Price
EUR 11.6
Price currency
EUR
Rev Per Employee
85,517.39x
Sic
8082
Symbol
fra/X34
Website
https://www.ehab.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
-0.47%
EV Earnings
-355.09x
EV/EBIT
15.03x
EV/EBITDA
9.76x
EV/FCF
14.05x
EV/Sales
1.09x
FCF yield
11.81%
Forward P/E
18.35x
P/B ratio
1.17x
P/S ratio
0.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
7.25%
EBITDA Margin
9.2%
FCF margin
7.6%
Gross margin
48.9%
Gross Profit
EUR 451.6M
Gross Profit Growth
3.13%
Gross Profit Growth Q
5.28%
Gross Profit Growth3 Y
-1.6%
Net Income
EUR -2.8M
Pretax Margin
-0.13%
Profit Margin
-0.3%
Profit Per Employee
EUR -257
ROA
4
Roa5y
3.25
ROCE
7.43
ROE
-0.19
Roe5y
-6.24
ROIC
-11.41
Roic5y
1.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr1y
65.77%
Cagr3y
0.29%
FCF Growth
38.82%
FCF Growth3 Y
-3.4%
OCF Growth
38.09%
OCF Growth3 Y
-4.08%
Revenue Growth
2.44x
Revenue Growth Q
4.73x
Revenue Growth3 Y
-0.35x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.88
Assets
EUR 1B
Cash
EUR 43.4M
Current Assets
EUR 174.3M
Current Liabilities
EUR 107.1M
Debt
EUR 416.4M
Debt EBITDA
EUR 4.04
Debt Equity
EUR 0.82
Debt FCF
EUR 5.93
Equity
EUR 506.4M
Interest Coverage
2.23
Liabilities
EUR 516M
Long Term Assets
EUR 848.1M
Long Term Liabilities
EUR 408.9M
Net Cash
EUR -373M
Net Cash By Market Cap
EUR -62.77
Net Debt EBITDA
EUR 4.39
Net Debt Equity
EUR 0.74
Net Debt FCF
EUR 5.32
Tangible Book Value
EUR -292.2M
Tangible Book Value Per Share
EUR -5.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
1.56
Net Working Capital
EUR 58.5M
Quick ratio
1.46
Working Capital
EUR 68.5M
Working Capital Turnover
EUR 12.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-1.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

32
MetricValue
1Y total return
65.71%
200-day SMA
8.51
3Y total return
0.87%
50-day SMA
11.66
50-day SMA vs 200-day SMA
50over200
All Time High
14.7
All Time High Change
-21.09%
All Time High Date
2023-02-16
All Time Low
5.6
All Time Low Change
107.14%
All Time Low Date
2025-08-04
ATR
0.07
Ch YTD
46.84
High
11.6
High52
12.2
High52 Date
2026-03-31
High52ch
-4.92%
Low
11.6
Low52
5.6
Low52 Date
2025-08-04
Low52ch
107.14%
Ma50ch
-0.53%
Price vs 200-day SMA
36.37%
RSI
51.52
RSI Monthly
59.37
RSI Weekly
73.4
Sharpe ratio
0.83x
Sortino ratio
1.53
Total Return
-1.2%
Tr YTD
46.84
Tr1m
-2.52%
Tr3m
26.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
EUR 67M
Operating Income Growth
36.91
Operating Income Growth Q
14.29
Operating Income Growth3 Y
-13.21
Operating margin
7.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
44,118,368%
Net Borrowing
-57,407,027.4
Shares Insiders
3.66%
Shares Institutions
81.54%
Shares Qo Q
-0.78%
Shares Yo Y
1.2%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Adjusted FCF
EUR 55.9M
Average Volume
0x
Bv Per Share
9.37
CAPEX
EUR -6.2M
Ch1m
-2.52
Ch1y
65.71
Ch3m
26.09
Ch3y
0.87
Ch6m
75.76
Change
0%
Change From Open
0
Close
11.6
Days Gap
0
Depreciation Amortization
19,079,145
Earnings Date
2026-05-14
EBIT
EUR 67M
EBITDA
EUR 85M
EPS
EUR -0.06
F Score
7
FCF
EUR 70.2M
FCF EV Yield
7.12x
Financing CF
-61,231,380
Fiscal Year End
December
Founded
1,998
Goodwill
725,261,898.6
Income Tax
EUR -260,190
Investing CF
-5,810,910
Is Primary Listing
0
Last Earnings Date
2026-03-04
Last Report Date
2025-12-31
Ma150
9.19
Ma150ch
26.24%
Ma20
11.6
Ma20ch
0%
Net CF
9,280,110
Next Earnings Date
2026-05-14
Open
11.6
P FCF Ratio
8.47
P OCF Ratio
7.79
Ppne
55,371,918.6
Price Date
2026-05-08
Price EBITDA
EUR 6.99
Relative Volume
2,000x
Revenue
923,587,770x
SBC By Revenue
1.55x
Share Based Comp
14,310,450
Tax By Revenue
-0.03x
Tr6m
75.76%
Volume
0
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/X34 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/X34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+65.7%
S&P 500 1Y: n/a
3Y total return
+0.9%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/X34?

Insider, institutional, and short-interest positioning.

Institutional ownership
+81.5%
Share of float held by funds and institutions
Insider ownership
+3.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+1.2%
Negative means the company is buying back shares.
Technical

FRA/X34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
51.5
Neutral momentum band
Price vs 200-day MA
+36.4%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.83
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/X34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/X34 stock rating?

fra/X34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/X34 analysis?

The full report lives at /stocks/fra/X34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/X34?

The latest report frames fra/X34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/X34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.